Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(10%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
3
30%
Ph phase_1
2
20%

Phase Distribution

2

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
3(30.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (20.0%)
Phase 23 (30.0%)
N/A5 (50.0%)

Trials by Status

unknown220%
recruiting110%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10